CDC5L

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA006302

Antibody HPA011361

Antibody CAB012275

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Moderate to strong cytoplasmic and nuclear staining in all malignant tissues. Strong staining in several cases of malignant melanomas and skin cancer.Malignant cells showed moderate to strong nuclear staining. Testicular and urothelial cancers showed strong immunoreactivity. Renal cancers were weakly stained or negative. Remaining malignancies showed weak to moderate nuclear positivity.

Validation

Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data
Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data
Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected